A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients
Titel:
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients
Auteur:
Stuart Elborn, J. Geller, David E. Conrad, Douglas Aaron, Shawn D. Smyth, Alan R. Fischer, Rainald Kerem, Eitan Bell, Scott C. Loutit, Jeffery S. Dudley, Michael N. Morgan, Elizabeth E. VanDevanter, Donald R. Flume, Patrick A.